Acrizanib,cas:1229453-99-9
5-[6-(methylaminomethyl)pyrimidin-4-yl]oxy-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]indole-1-carboxamide
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-XASYS-00604 | 5mg | 1603.00 | + Add to cart |
|
R-XASYS-00604 | 10mg | 2478.00 | + Add to cart |
|
|
Product description
Acrizanib(C20H18F3N7O2,445.41),also known as LHA510, is a potent and selective angiogenesis inhibitor and VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.
Appearance | N/A |
---|---|
Molecular Weight | N/A |
Purity | >90% |
Solubility | N/A |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 1 year |
Document
Related Product